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Abstract The miR-17–92 cluster encoding 6 single
mature miRNAs was identified a couple of years ago
to contain the first oncogenic miRNAs. Now, one of
these 6 miRNAs, miR-19 has been identified as the key
responsible for this oncogenic activity. This in turn
reduces PTEN levels and in consequence activates the
AKT/mTOR pathway that is also prominently
involved in modulation of organismal life spans. In
contrast, miR-19 and other members of the miR-17–92
cluster are found to be commonly downregulated in
several human replicative and organismal aging
models. Taken together, these findings suggest that
miR-19 and the other members of the miR-17–92
cluster might be important regulators on the cross-
roads between aging and cancer. Therefore, we here
briefly summarize how this cluster is transcriptionally
regulated, which target mRNAs have been confirmed
so far and how this might be linked to modulation of
organismal life-spans.
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It is not long ago that the first miRNA cluster has
been identified with oncogenic potential and was
therefore termed oncomiR-1 (He et al. 2005). Now,
two recent reports have been able to pin down
miR-19 as the key oncogenic miRNA of this cluster
containing 6 miRNA members (Mu et al. 2009; Olive
et al. 2009). Furthermore, the idea that miRNAs also
play a role in aging is increasingly substantiated
(Grillari and Grillari-Voglauer 2010; Bates et al.
2009). Recently, a large scale microRNA microarray
analysis of 4 different cell types in replicative
senescence and 3 different tissue types ex vivo
representing organismal aging was performed (Hackl
et al. 2010). Thereby, a common down-regulation of
miR-17, 19b, 20a and miR-106a, members of the
miR-17–92 and paralogous cluster, was found (see
Table 1 for an overview of the clusters, their
members, and their seed sequences). This indicates
that this cluster represents one additional important
player not only in the complex regulatory network of
cell cycle and tumorigenesis, but also in aging,
emphasising that these processes are intricately
interwoven (Campisi 2003). Even more so, as
miR-19 upregulation in cancer activates the AKT-mTOR
pathway via PTEN silencing (Olive et al. 2009). It is
tempting to speculate therefore, that decrease of miR-19
might lead to increased PTEN and in consequence
repress AKT-mTOR, a pathway that has been clearly
linked with modulation of life-span in a variety of
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model organisms (Kapahi et al. 2004; Blagosklonny
2007; Schieke and Finkel 2007) and even in mouse,
where the mTOR inhibitor rapamycin leads to a life-
span extension (Harrison et al. 2009).
Thus, understanding the regulatory network of this
cluster might well increase our knowledge on why
advancing age is the largest single risk factor to
develop cancer. Therefore, we here want to briefly
summarize the current knowledge on the regulation
loops of this cluster (Fig. 1) especially in regard to
senescence that has been largely accepted as tumor
suppressor mechanism in vivo (reviewed in Hornsby
2007; Sedivy 2007) and aging.
Transcriptional regulation of the miR-17–92
cluster
So far, c-MYC (O’Donnell et al. 2005), E2F1 and 3
(Petrocca et al. 2008b), as well as STAT3 (Brock
et al. 2009) have been identified to transcriptionally
activate the miR-17–92 cluster and paralogous clus-
ters, while p53 represses it (Yan et al. 2009).
However, MYC does not seem to change in senes-
cence (Chang and Chen 1988; Seshadri and Campisi
1990), even though tumour cells enter senescence
upon MYC inactivation (Wu et al. 2007). Similarly,
STAT3 seems not to be involved, even if it might be
Table 1 Overview on the miRNAs of the miR-17–92 cluster as well as of its paralogous clusters miR-106a–32 and miR-106b–25
microRNA Seed family Genomic location Seed sequence Mature miRNA sequence
hsa-miR-17 miR-17–92 AAAGUG CAAAGUGCUUACAGUGCAGGUAG
hsa-miR-20a miR-17–92 AAAGUG UAAAGUGCUUAUAGUGCAGGUAG
hsa-miR-106a miR-17 miR-106a–363 AAAGUG AAAAGUGCUUACAGUGCAGGUAG
hsa-miR-20b miR-106a–363 AAAGUG CAAAGUGCUCAUAGUGCAGGUAG
hsa-miR-106b miR-106b–25 AAAGUG UAAAGUGCUGACAGUGCAGAU
hsa-miR-93 miR-106b–25 AAAGUG CAAAGUGCUGUUCGUGCAGGUAG
hsa-miR-18a miR-18 miR-17–92 AAGGUG UAAGGUGCAUCUAGUGCAGAUAG




hsa-miR-19b miR-17–92 GUGCAA UGUGCAAAUCCAUGCAAAACUGA
hsa-miR-25 miR-106b–25 AUUGCA CAUUGCACUUGUCUCGGUCUGA
hsa-miR-92a miR-25 miR-17–92 AUUGCA UAUUGCACUUGUCCCGGCCUGU
hsa-miR-363 miR-106a–363 AUUGCA AAUUGCACGGUAUCCAUCUGUA
Fig. 1 Overview on
transcriptional regulation
and target mRNAs of the
miR-17–92 cluster
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expected to rise with senescence in response to the
senescence-dependent increase of secreted IL-6 and
IL-8 (Acosta et al. 2008) which are upstream
activators of STAT3. Why in turn the miR-17–92
cluster is decreased instead of activated is unclear.
STAT3 might be blocked at the post-translational
level, since it is very susceptible to oxidation and is
easily S-glutathionylated. In consequence of this
modification, it is not activated by JAK anymore
and does not translocate to the nucleus (Xie et al.
2009). High levels of S-glutathionylated, and thus
inhibited STAT3 might be possible due to high levels
of S-glutathione transferase P that are known to be
present in senescent cells (Chang et al. 2005).
Thus, two responsible transcriptional regulators
remain to most probably account for less miR-17–92
in senescence. Less E2F family members have been
observed in senescent cells (Dimri et al. 1994), and
p53, which is a decisive switch in aging and
tumorigenesis (Rodier et al. 2007; Schmid et al.
2007) is increasingly active in senescence (Atadja
et al. 1995; Kulju and Lehman 1995) and might thus
contribute by actively repressing miR-17–92 (Yan
et al. 2009).
Table 2 Published mRNA targets of the miR-17–92 cluster members
Target Gene Symbol MicroRNA Refs
APP miR-106a Patel et al. (2008)
BCL2L11 (Bim) miR-17 Cloonan et al. (2008)
CCND1 miR-17, miR-20a Yu et al. (2008)
CDKN1A (p21) miR-106a, miR-106b, miR-17 Cloonan et al. (2008), Li et al. (2009), Ivanovska et al. (2008)
CDKN1C (p57) miR-92b Sengupta et al. (2009)
CTGF miR-18a Cloonan et al. (2008), Ohgawara et al. (2009)
E2F1 miR-106b, miR-20a Petrocca et al. (2008a, b), O’Donnell et al. (2005),
Pickering et al. (2009)
GAB1 miR-17 Cloonan et al. (2008)
HIF-1a miR-17-92 Taguchi et al. (2008)
HIPK3 miR-92a Landais et al. (2007)
IRF1 miR-17 Cloonan et al. (2008)
ITCH miR-106b Sampath et al. (2009)
MAPK9 miR-17 Cloonan et al. (2008)
MAPK14 miR-17, miR-20a, miR-106b Carraro et al. (2009)
MYLIP miR-92a Landais et al. (2007)
NCOA3 miR-17 Cloonan et al. (2008), Hossain et al. (2006)
NR4A3 miR-17 Cloonan et al. (2008)
p63 miR-92 Manni et al. (2009)
PCAF miR-17, miR-20a Cloonan et al. (2008)
PKD1, PKD2 miR-17 Cloonan et al. (2008)
PPARA-C miR-17 Cloonan et al. (2008)
PTEN miR-19a Cloonan et al. (2008), Lewis et al. (2003)
RB1 miR-106a Volinia et al. (2006), Cloonan et al. (2008)
RB2/p130 miR-17-92 Wang et al. (2008)
RUNX1 miR-106a, miR-17, miR-20a Fontana et al. (2007), Cloonan et al. (2008), Yu et al. (2008)
SOCS-1 miR-19a, miR-19b Pichiorri et al. (2008)
STAT3 miR-17, miR-20a, miR-106b Carraro et al. (2009)
TGFBR2 miR-17, miR-20a Cloonan et al. (2008), Volinia et al. (2006)
THBS1 miR-19a Cloonan et al. (2008)
TSG101 miR-17 Cloonan et al. (2008)
VEGFA miR-106a, miR-106b, miR-17, miR-20a Ye et al. (2008)
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Targets of the miR-17–92 cluster
Around 30 mRNA targets have been experimentally
confirmed so far (Table 2), among them BCL2L11
(Bim), IRF, JNK2/MAPK9, MYCN, PKD1, PKD2,
GAB1, RBL1, TSG101 (Cloonan et al. 2008), p63
(Manni et al. 2009), STAT3 and p38/Mapk14 (Carr-
aro et al. 2009), the TGFb signal pathway (Petrocca
et al. 2008a), HIF-1a (Taguchi et al. 2008), or Rbl2/
p130 (Wang et al. 2008), p57, p27 and p21 all
involved in tumorigenesis and cell cycle control.
Especially p21 transcription is well correlated with
miR-17, 19b, 20a and miR-106a in the replicative and
organismal aging model systems described above
(Hackl et al. 2010).
Indeed, miR-17–92 suppression induces complete
growth arrest in an anaplastic thyroid cancer cell model
(Takakura et al. 2008). In contrast, overexpression of
one of its members in mouse embryonic fibroblasts,
miR-20a, induces senescence by reducing Leukemia/
lymphoma Related Factor (LRF) levels (Poliseno et al.
2008), indicating that cell type specific responses are
possible in response to miR-17–92. This is consistent
with the notion that overexpression of miR-106a that
derives from a paralogous cluster, targets p21 in human
fibroblasts and trabecular meshwork cells (Li et al.
2009). Finally, overexpression of miR-17–92 inhibits
generation of ROS and DNA damage in RB mutated
tumor cells (Ebi et al. 2009).
It will be exciting to see if the opposite, reduction
of miR-17–92 will result in more ROS and DNA
damage, as well as block of tissue repair by inhibition
of stem cell self renewal. All of these are well
accepted driving forces of age-related functional
decline.
Conclusion
It is still unclear, how and why miR-17–92 is
downregulated during aging and senescence. Future
work will have to reveal if it is cause or consequence
and to what extent its downregulation functionally
contributes to aging or even to tumor suppression
during aging. In any case, members of this cluster
might represent novel biomarkers of aging and the
link between miR-17–92 and AKT/mTOR via PTEN
might provide a novel regulatory loop of life span
modulation.
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